We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$377B
AUM Growth
+$49.7B
Cap. Flow
+$31.3B
Cap. Flow %
8.3%
Top 10 Hldgs %
41.14%
Holding
5,593
New
785
Increased
2,954
Reduced
1,009
Closed
322

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Financials 7.13%
3 Consumer Discretionary 6.46%
4 Healthcare 5.43%
5 Communication Services 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFTR
5076
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$4 ﹤0.01%
100
GEVO icon
5077
Gevo
GEVO
$353M
$3 ﹤0.01%
2
SEATW icon
5078
Vivid Seats Inc Warrant
SEATW
$3 ﹤0.01%
+100
New +$49
OGI
5079
Organigram Holdings
OGI
$131M
$2 ﹤0.01%
1
-9,375
-100% -$16.3K
ORGN
5080
DELISTED
Origin Materials
ORGN
-1,297
Closed -$47K
SHIM icon
5081
Shimmick
SHIM
$157M
$2 ﹤0.01%
+1
New +$3
CTXR icon
5082
Citius Pharmaceuticals
CTXR
$15.6M
-1,513
Closed -$25.5K
KZR
5083
DELISTED
Kezar Life Sciences
KZR
-22
Closed -$133
MBOT icon
5084
Microbot Medical
MBOT
$112M
$1 ﹤0.01%
1
MLSS icon
5085
Milestone Scientific
MLSS
$33.3M
$1 ﹤0.01%
1
SGMO
5086
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1 ﹤0.01%
1
-54,511
-100% -$39.9K
SKYX icon
5087
SKYX Platforms
SKYX
$143M
$1 ﹤0.01%
1
-36,467
-100% -$34.3K
VUZI icon
5088
Vuzix
VUZI
$178M
$1 ﹤0.01%
1
WKHS icon
5089
Workhorse Group
WKHS
$33.4M
-1
Closed -$169
WW
5090
DELISTED
WW International
WW
$1 ﹤0.01%
1
-66
-99% -$64
AA icon
5091
CALL
Alcoa
AA
$11.3B
-768,500
Closed -$30.6M
A icon
5092
CALL
Agilent Technologies
A
$39.6B
-309,500
Closed -$40.1M
ABX
5093
Abacus Global Management
ABX
$988M
-11,831
Closed -$102K
ABNB icon
5094
CALL
Airbnb
ABNB
$90.8B
-598,500
Closed -$90.8M
ACWI icon
5095
CALL
iShares MSCI ACWI ETF
ACWI
$32B
-1,350,000
Closed -$152M
ADM icon
5096
CALL
Archer Daniels Midland
ADM
$38.7B
-6,300
Closed -$381K
ADP icon
5097
CALL
Automatic Data Processing
ADP
$109B
-33,800
Closed -$8.07M
AEO icon
5098
CALL
American Eagle Outfitters
AEO
$2.94B
-90,900
Closed -$1.81M
ALB icon
5099
CALL
Albemarle
ALB
$13.4B
-825,500
Closed -$78.9M
ALL icon
5100
CALL
Allstate
ALL
$70.6B
-49,400
Closed -$7.89M

Similar funds

Barclays's Q3 2024 Portfolio in Review

As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.

  • Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
  • Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
  • Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
  • Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
  • Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
  • Barclays opened 785 new positions and closed 322 in Q3 2024.
  • Barclays's portfolio value rose 15% quarter-over-quarter to $377B.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.